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Purpose: The identification of sick sinus syndrome (SSS) in patients with atrial 
flutter (AFL) is difficult before the termination of AFL. This study investigated the 
patient characteristics used in predicting a high risk of SSS after AFL ablation. 
Materials and Methods: Out of 339 consecutive patients who had undergone ra-
diofrequency ablation for AFL from 1991 to 2012, 27 (8%) had SSS (SSS group). 
We compared the clinical characteristics of patients with and without SSS (n=312, 
no-SSS group). Results: The SSS group was more likely to have a lower body 
mass index (SSS: 22.5±3.2; no-SSS: 24.0±3.0 kg/m2; p=0.02), a history of atrial 
septal defects (ASD; SSS: 19%; no-SSS: 6%; p=0.01), a history of coronary artery 
bypass graft surgery (CABG; SSS: 11%; no-SSS: 2%; p=0.002), and a longer flut-
ter cycle length (CL; SSS: 262.3±39.2; no-SSS: 243.0±40; p=0.02) than the no-
SSS group. In multivariate analysis, a history of ASD [odds ratio (OR) 3.7, 95% 
confidence interval (CI) 1.2‒11.4, p=0.02] and CABG (7.1, 95% CI 1.5‒32.8, 
p=0.01) as well as longer flutter CL (1.1, 95% CI 1.0‒1.2, p=0.04) were indepen-
dent risk factors for SSS. Conclusion: A history of ASD and CABG as well as lon-
ger flutter CL increased the risk of SSS after AFL ablation. While half of the pa-
tients with SSS after AFL ablation experienced transient SSS, heart failure was 
associated with irreversible SSS.
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INTRODUCTION
Atrial flutter (AFL) is the second most common atrial tachyarrhythmia after atrial 
fibrillation. Catheter ablation for typical AFL has been well established and en-
sures a high success rate and adequate safety.1 However, sick sinus syndrome 
(SSS) is occasionally uncovered when long-term, persistent AFL is terminated by 
ablation.2,3 Permanent pacemaker implantation is necessary in these cases. Sinus 
node function cannot be assessed during AFL, and preoperative prediction of un-
derlying SSS has not yet been investigated. Currently, there is limited data on this 
issue.
The purpose of this study is to investigate the predictors of SSS before AFL ab-
lation in patients with persistent AFL.
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tioned in the right atrium (RA), parallel to the TA so that 
the distal pole was located in the medial region of the CTI. 
A decapolar catheter was inserted within the coronary sinus 
(CS), with the proximal bipole located at the ostium. Quad-
ripolar catheters were positioned at the His bundle and RA. 
Then, a non-irrigated ablation catheter with a 4 or 8 mm tip 
was placed close to the right ventricle (RV), within the CTI. 
Bipolar intracardiac electrograms that were filtered between 
30 and 500 Hz were digitally recorded and stored simulta-
neously with a 12-lead surface ECG.
The flutter cycle length (CL) was preliminarily calculated 
as an average over 10 consecutive cycles in lead V1 by a 
surface ECG performed the day before the ablation proce-
dure. In the same fashion, the flutter CL was measured at 
the proximal CS 10 min after insertion of the sheaths with-
out any sedation so that the calculated value would not be 
affected by changes in autonomic tone resulting from veni-
puncture or sedative drugs. The ventricular cycle length 
during AFL was measured with a surface ECG in the same 
manner. Cavotricuspid isthmus dependence was confirmed 
if concealed entrainment was identified when pacing the 
CTI4,5 and if the difference between the post-pacing interval 
at the CTI and flutter CL was within 30 ms. A counter-
clockwise or clockwise activation sequence around the TA 
during AFL was confirmed by sequential mapping in pa-
tients with typical flutter waves and by both sequential 
mapping and electroanatomic mapping with a CARTO sys-
tem (Biosense Webster) in patients with atypical flutter 
waves. Subsequently, a linear lesion was made by continu-
ously applying radiofrequency energy with a temperature 
target of 60°C and a power limit of 50 W during a stepwise 
withdrawal of the ablation catheter from the RV and to-
wards the inferior vena cava. Procedural success was de-
fined as the termination of AFL during the radiofrequency 
application and the creation of a bidirectional CTI block.
Twenty minutes after successful AFL ablation, baseline 
intracardiac conduction intervals, including the sinus rhythm 
cycle length, atrio-His (AH), and His-ventricle (HV) inter-
vals, were measured during sinus rhythm.
Pacemaker implantation
Patients received isoproterenol infusion or temporary pac-
ing from a catheter within the RA if they manifested any 
significant SSS following AFL termination by the catheter 
ablation. Sick sinus syndrome was defined as a syndrome 
encompassing a number of sinus node abnormalities, in-
cluding the following: 1) persistent spontaneous sinus bra-
MATERIALS AND METHODS
Study population
The patient population included 339 consecutive patients 
who had undergone radiofrequency catheter ablation for 
AFL at Severance Cardiovascular Hospital from January 
1996 to May 2012. Patients were enrolled retrospectively in 
a registry. Inclusion criteria were as follows: 1) cavotricus-
pid isthmus (CTI) participation in the arrhythmic circuit 
confirmed by an EP study, 2) an atrial activation pattern dur-
ing atrial tachycardia showing a clockwise or counterclock-
wise rotation around the tricuspid annulus (TA), 3) termina-
tion of the AFL by CTI linear ablation, and 4) atypical flutter 
involving the atriotomy.
Typical AFL was diagnosed when a surface ECG showed 
flutter waves that were predominantly negative in leads II, 
III, and aVF and positive in lead V1, with a regular atrial 
rate. Also enrolled were patients with a surface ECG un-
characteristic of typical AFL as well as those with typical 
AFL whose atrial tachyarrhythmias were confirmed to have 
arrhythmic circuits including the CTI and tricuspid annulus. 
Patients were excluded if they had previously undergone 
AFL ablation or implantation of a pacemaker for SSS.
Patient histories, baseline characteristics, procedural data, 
and follow-up information were collected by a retrospective 
query of all records within a computerized patient record 
system. The database contained information about patient 
demographics and preprocedural risk factors, including age, 
body mass index, congestive heart failure, hypertension, di-
abetes mellitus, prior transient ischemic attack or stroke, 
dyslipidemia, coronary artery disease, vascular disease, 
congenital heart disease, cardiomyopathy, and preprocedure 
atrial fibrillation (AF). Preprocedure echocardiograms were 
reviewed to determine the left ventricular ejection fraction, 
left atrial size, left atrial volume index, and E/E’. The use of 
medications, including antiplatelet drugs (e.g., aspirin, clop-
idogrel), warfarin, and antiarrhythmic drugs was document-
ed as well. 
Electrophysiological study and catheter ablation
All antiarrhythmic agents were ceased ≥5 half-lives before 
the electrophysiological (EP) procedure, and a signed con-
sent form was obtained from each patient. Electrophysio-
logical studies were performed in the postabsorptive state. 
A duodecapolar catheter with 2-5-2 mm interelectrode 
spacing (St. Jude Medical, St. Paul, MN, USA) was posi-
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or not. Univariate comparisons were performed using Stu-
dent’s t-test or the Mann-Whitney U test for continuous vari-
ables and a chi-square test or Fisher’s test for categorical 
variables. A multivariate analysis was performed to identify 
predictors associated with sinoatrial node dysfunction. Statis-
tical significance was established at a value of p<0.05. Statis-
tical analysis was performed by SPSS Version 18.0 (SPSS 
Inc., Chicago, IL, USA).
 
RESULTS
 
Patient characteristics
A total of 350 patients were considered eligible for inclu-
sion; however, 11 patients were excluded from our study 
due to the following reasons: 6 patients had previous AFL 
ablations and 5 had previous pacemaker implantations for 
SSS. Finally, a total of 339 patients (mean age 56±14 years, 
73 women) were enrolled in our study. After successful AFL 
dycardia not caused by drugs and inappropriate for the 
physiological circumstance, 2) sinus arrest or exit block, 3) 
a combination of SA and atrioventricular conduction distur-
bance, or 4) an alternation of paroxysms of rapid regular or 
irregular atrial tachyarrhythmias and periods of slow atrial 
and ventricular rates.6 The indication for temporary pacing 
included one or more of the following with or without symp-
toms such as syncope, dizziness and dyspnea: 1) sinus bra-
dycardia with a heart rate of <40 beats/min, 2) sinus arrest, 
or 3) repeated sinus pauses longer than 3 s. Patients who 
had bradycardia-related symptoms resulting from the above 
EP abnormalities after the CTI ablation had permanent du-
al-chamber pacemakers implanted.
Statistical analysis
Continuous data are expressed as mean±SD, and categorical 
variables are expressed as counts and percentages (%). Nor-
mality tests were performed for each variable to determine 
whether a data set was well modeled by a normal distribution 
Table 1. Clinical Characteristics of the Study Patients
SSS (n=27) No SSS (n=312) p value
Age, yrs   58±16   56±14 0.34
Female, n (%)   8 (30)   65 (21) 0.29
Body mass index, kg/m2 22.5±3.2 24.0±3.0 0.02
Duration of AFL, months   3.2±3.2   4.4±4.0 0.16
Prior cardiac surgery   6 (22)   36 (12) 0.08
    RAtomy   3 (11) 23 (7) 0.49
    History of CABG   3 (11)   5 (2) 0.002
    Valve OP 1 (4)   9 (3) 0.81
ASD*   5 (19) 18 (6) 0.01
TOF* 1 (4) 10 (3) 0.89
Structural heart disease
    Valvular heart disease   4 (15)   35 (11) 0.58
    Ischemic heart disease   4 (15) 29 (9) 0.36
    Non-ischemic cardiomyopathy 0 (0) 20 (6) 0.18
Congestive heart failure   4 (15) 23 (7) 0.31
Hypertension   8 (30) 105 (34) 0.67
Diabetes mellitus   4 (15)   57 (18) 0.66
LV ejection fraction, %   57±11   61±11 0.06
LA diameter, mm 43±5 42±6 0.67
Antiarrhythmic drugs or digitalis, n (%)
    Class I   5 (19) 104 (33) 0.08
    Class III 0 (0)   37 (12) <0.001
    Beta blocker   8 (30)   55 (18) 0.2
    Calcium channel blocker   5 (19)   72 (23) 0.59
    Digitalis   6 (22) 23 (7) 0.008
ASD, atrial septal defect; CABG, coronary artery bypass graft; LA, left atrium; LV, left ventricle; RA, right atrium; TOF, tetralogy of Fallot; AFL, atrial flutter; 
SSS, sick sinus syndrome; OP, operation.
*Two patients had both ASD and TOF.
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likely to have atypical flutter waves (SSS: 30%; no-SSS: 
3%; p=0.006) and longer flutter CLs (SSS: 262±39 ms; no-
SSS: 243±40 ms; p=0.02). QRS duration, sinus rhythm CL, 
AH interval, and HV interval revealed no statistical differ-
ences between the two groups.
Independent predictors of SSS
In the univariate logistic regression analysis, age >75 years, 
low body mass index, history of CABG surgery, prior cardi-
ac surgery for ASD, longer flutter CL, and antiarrhythmic 
drug and digitalis use emerged as predictors of SSS after 
AFL ablation. In multivariate models, history of CABG sur-
gery [odds ratio (OR) 7.1, 95% confidence interval (CI) 
1.5‒32.8, p=0.01], history of ASD (OR 3.7, 95% CI 1.2‒11.4, 
p=0.02), and longer flutter CL (OR 1.1, 95% CI 1.0‒1.2, 
p=0.04) were independent predictors of SSS (Table 3).
Recovery of SSS after ablation of AFL
Out of 27 patients with SSS, 14 had transient SSS with a 
mean duration of 19.9±23.1 hours after AFL ablation. Thir-
teen patients had irreversible SSS, including 4 with junction-
al escape rhythms and 9 with sinus bradycardia. During the 
6.0±4.2 years (range: 1‒16.1 years) follow up, 8 of 27 pa-
tients (30%) required permanent pacemaker implantation. 
The mean time of pacemaker implantation after AFL abla-
ablation, 27 patients (8%) had SSS and needed isoprotere-
nol infusion or temporary pacing.
The baseline characteristics of patients with or without 
SSS are summarized in Table 1. In 37 out of 329 patients 
(11.2%), AFL was combined with AF. The prevalence of AF 
between two groups revealed no statistical difference (SSS: 
11.1%; no-SSS: 11.3%; p=0.98). Patients with SSS were 
more likely to have a lower body mass index (SSS: 22.5±3.2 
kg/m2; no-SSS: 24.0±3.0 kg/m2; p=0.02), a history of atrial 
septal defect (ASD; SSS: 19%; no-SSS: 6%; p=0.01), and a 
history of coronary artery bypass graft surgery (CABG; SSS: 
11%; no-SSS: 2%; p=0.002). We observed a trend of higher 
incidence of congestive heart failure in the SSS group than in 
the no-SSS group (SSS: 15%; no-SSS: 7%; p=0.31). Among 
23 patients (7%) with ASD, 19 patients had secundum 
ASDs, 3 had primum ASDs, and 1 had a sinus venosus 
ASD. All patients with SSS had ostium secundum ASDs. 
While class III antiarrhythmic drugs were more frequently 
prescribed in patients with no SSS (SSS: 0%; no-SSS: 12%; 
p<0.001), digitalis was prescribed more frequently in those 
with SSS (SSS: 22%; no-SSS: 7%; p=0.008). 
Electrophysiological characteristics of the study group
Table 2 represents the electrophysiological parameters in 
patients with or without SSS. Patients with SSS were more 
Table 2. Pre- and Post-Ablation Electrophysiological Parameters
Variable SSS (n=27) No SSS (n=312) p value
Atypical flutter waves, n (%) 8 (30) 9 (3)   0.006
Flutter CL, ms 262±39 243±40 0.02
QRS duration, ms   82±17   95±21 0.22
Sinus rhythm CL, ms   994±467   887±293 0.28
AH interval, ms 135±46 115±44 0.30
HV interval, ms   62±14   54±19 0.36
AH, atrio-His; CL, cycle length; HV, His-ventricle; SSS, sick sinus syndrome.
Table 3. Predictors of Sick Sinus Syndrome after Univariate and Multivariate Analyses (n=339)
Variable
Univariate Multivariate
OR (95% CI) p value OR (95% CI) p value
Age >75 yrs 3.80 (1.25‒11.58) 0.02
Body mass index 0.85 (0.75‒0.98) 0.02
Congestive heart failure 2.19 (0.70‒6.86) 0.18
CABG 7.93 (1.78‒35.29)   0.007   7.1 (1.5‒32.8) 0.01
ASD 3.71 (1.26‒10.95) 0.02   3.7 (1.2‒11.4) 0.02
Flutter CL, per 10 msec 1.12 (1.02‒1.23) 0.02 1.1 (1.0‒1.2) 0.04
LV ejection fraction 0.97 (0.94‒1.00) 0.07
Antiarrhythmic drugs 0.28 (0.10‒0.76) 0.01
Digitalis 3.76 (1.37‒10.28) 0.01
CABG, coronary artery bypass graft; ASD, atrial septal defect; LV, left ventricle; CL, cycle length; OR, odds ratio; CI, confidence interval.
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use was more common in patients with reversible SSS.
Previous cardiac surgery and SSS
Increased risk of SSS after open-heart surgery has repeated-
ly been identified in previous studies,7,8 and a similar trend 
was also observed in the present analysis. Direct damage to 
the sinus node or sinus node blood supply during cardiac 
surgery has been suggested as the causal mechanism. We 
observed a significant trend towards an association between 
atypical flutter waves and SSS, and this may be causally re-
lated to previous open-heart surgery as well. In typical AFL, 
the sites with conduction delay are located in the CTI and 
crista terminalis; however, in atypical AFL, other sites with 
conduction delay exist, likely produced by previous surgi-
cal scars.9 History of ASD or CABG surgery itself may be 
predictors of sinus node dysfunction after atrial flutter abla-
tion. Therefore, it is vital to be able to predict the manifesta-
tion of SSS after AFL ablation in these patients.
Relationship between atrial remodeling and SSS
In this study, the CL of AFL was longer in patients with SSS 
tion was 20.5 days (interquartile range: 15.25‒38.25 days). 
One patient needed a pacemaker at 1 year 7 months after 
AFL ablation. Patients with irreversible SSS had heart fail-
ure more frequently than those with reversible SSS (irre-
versible: 31%; reversible: 0%; p=0.03). Hypertension (irre-
versible: 8%; reversible: 50%; p=0.009) and beta blocker 
use (irreversible: 8%; reversible: 50%; p=0.02) were more 
common in patients with reversible SSS (Table 4). 
DISCUSSION
Major findings
In the present study, we evaluated the patient characteristics 
that predicted a high risk of SSS after successful AFL abla-
tion. In observing the 8% of patients who had SSS after 
successful AFL ablations, we found that a history of cardiac 
surgery for ASD and CABG as well as a longer flutter CL 
increased the risk of SSS. Half of SSS cases after AFL abla-
tion were transient and improved within one day. Heart fail-
ure was associated with irreversible SSS, and beta blocker 
Table 4. Clinical Characteristics of Patients with Irreversible and Reversible SSS
Irreversible (n=13) Reversible (n=14) p value
Age, yrs   57±19   59±14 0.80
Female, n (%)   4 (31)   4 (29) 0.91
Body mass index, kg/m2 22.1±3.2 22.8±3.3 0.59
Duration of AFL, months   3.4±4.8   3.0±3.1 0.33
Prior cardiac surgery 1 (8)   5 (36) 0.60
    RAtomy 1 (8)   2 (14)
    History of CABG 0 (0)   3 (21) 0.10
    Valve OP 0 (0) 1 (7)
ASD   3 (23)   2 (14) 0.57
TOF 1 (8) 0 (0) 0.31
Structural heart disease
    Valvular heart disease 1 (8)   3 (21) 0.33
    Ischemic heart disease 1 (8)   3 (21) 0.38
    Cardiomyopathy 0 (0) 0 (0)
Congestive heart failure   4 (31) 0 (0) 0.03
Hypertension 1 (8)   7 (50)   0.009
Diabetes mellitus 1 (8)   3 (21) 0.30
LV ejection fraction, %   57±11   58±12 0.88
LA diameter, mm 43±5 43±5 0.71
Antiarrhythmic drug use, n (%)
    Class I or III antiarrhythmic drugs 1 (8)   4 (29) 0.18
    Beta blocker 1 (8)   7 (50) 0.02
    Calcium channel blocker 1 (8)   4 (29) 0.18
    Digitalis   4 (31)   2 (14) 0.27
SSS, sick sinus syndrome; AFL, atrial flutter; RA, right atrium; CABG, coronary artery bypass graft; ASD, atrial septal defect; TOF, tetralogy of Fallot; LV, left 
ventricle; LA, left atrium; OP, operation.
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clinical practice. Thus, it is desirable to conduct a prospec-
tive study including selected populations in the future.
Conclusion
History of cardiac surgery for ASD and CABG as well as 
longer flutter CL increased the risk of SSS after AFL abla-
tion. This result suggests that flutter CL prior to ablation can 
be helpful for risk stratification of patients with persistent 
AFL who may develop SSS requiring a pacemaker implan-
tation. Also, the flutter CL may yield important information 
regarding atrial remodeling. Finally, heart failure was associ-
ated with irreversible SSS.
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